Market Overview

ExxonMobil and Synthetic Genomics, Inc. to Brief Media on Algae Research Breakthrough at 2017 BIO International Convention


Scientists from Exxon
Mobil Corporation
(NYSE:XOM) and Synthetic Genomics, Inc. will hold
a press briefing today at the 2017 BIO International Convention in San
Diego to discuss a breakthrough in the companies' research into the
development of algae biofuels involving the modification of an algae
strain that more than doubled its oil production without significantly
inhibiting the strain's growth. Results of the research were published
today in the peer-reviewed journal Nature Biotechnology
. A
press release is available at

Vijay Swarup, vice president for research and development at ExxonMobil
Research & Engineering Company, J. Craig Venter, Ph.D., co-founder and
chairman of Synthetic Genomics, and Oliver Fetzer, Ph.D., chief
executive officer at Synthetic Genomics, will discuss the research
breakthrough and answer questions from media.

The press briefing is scheduled for 10 a.m. PDT at the San Diego
Convention Center, located at 111 W. Harbor Drive, in Room 32B on the
upper level. The live briefing and replay may also be accessed online
via an interactive webcast.

Cautionary Statement: Statements of
future events or conditions in this release are forward-looking
statements. Actual future results, including the timing, results and
impact of new technologies, could differ significantly depending on the
outcome of further research and testing; the development and
competitiveness of alternative technologies; the ability to develop and
scale pilot projects on a cost-effective basis; political and regulatory
developments; and other factors discussed in this release and under the
heading "Factors Affecting Future Results" on the Investors page of
ExxonMobil's website at

About ExxonMobil

ExxonMobil, the largest publicly traded international energy company,
uses technology and innovation to help meet the world's growing energy
needs. ExxonMobil holds an industry-leading inventory of resources, is
one of the largest refiners and marketers of petroleum products and its
chemical company is one of the largest in the world. For more
information, visit
or follow us on Twitter

About Synthetic Genomics

Synthetic Genomics is programming the operating system of life to create
sustainable solutions for humankind's most pressing issues, from the
wellbeing of our population to the health of our planet. With an
unmatched understanding of how DNA drives the function of cells — the
basic biological units of all living organisms — Synthetic Genomics
modifies and writes genomes to enable transformative products in the
areas of vaccines, medicines, nutrition, and biotechnology research. In
addition to designing novel organisms that overcome fundamental hurdles
of scientific research and medicine, Synthetic Genomics pursues
partnerships with organizations seeking to dramatically improve upon
existing products in health care, energy, and other sectors. Continuing
its legacy of scientific firsts in genomics and synthetic biology,
Synthetic Genomics is harnessing the power of nature to improve quality
of life. More information is available at

View Comments and Join the Discussion!